Log in to save to my catalogue

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerati...

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c4fe83e08ac45f7a70500e5d1f2a6ab

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report

About this item

Full title

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2022-01, Vol.22 (1), p.22-22, Article 22

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Therapy regimens used in patients with inflammatory Bowel Disease (IBD) have been associated with enhanced risk of viral infections or viral reactivation. Moreover, it is uncertain whether IBD patients have increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or infected patients may have an increased risk for se...

Alternative Titles

Full title

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4c4fe83e08ac45f7a70500e5d1f2a6ab

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c4fe83e08ac45f7a70500e5d1f2a6ab

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-022-02094-3

How to access this item